Kunlun Wang

1.1k total citations
24 papers, 887 citations indexed

About

Kunlun Wang is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kunlun Wang has authored 24 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kunlun Wang's work include Esophageal Cancer Research and Treatment (6 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Kunlun Wang is often cited by papers focused on Esophageal Cancer Research and Treatment (6 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Kunlun Wang collaborates with scholars based in China and United States. Kunlun Wang's co-authors include Xiuhua Zhao, Yuangang Zu, Yunlong Ge, Ling Yuan, Ying Zhang, Shan Chang, Yong Li, Weiguo Wang, Shengbo Cao and Yu Lan and has published in prestigious journals such as PLoS ONE, Journal of Virology and International Journal of Pharmaceutics.

In The Last Decade

Kunlun Wang

23 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kunlun Wang China 13 162 144 142 136 136 24 887
María Jesús Lamas Spain 20 174 1.1× 98 0.7× 58 0.4× 179 1.3× 201 1.5× 74 1.2k
Barbara Mognetti Italy 20 120 0.7× 57 0.4× 124 0.9× 152 1.1× 109 0.8× 50 1.1k
Junyi Zhou China 22 84 0.5× 172 1.2× 324 2.3× 98 0.7× 129 0.9× 60 1.6k
Douaa Sayed Egypt 21 60 0.4× 88 0.6× 122 0.9× 117 0.9× 74 0.5× 66 1.2k
Jayabalan Nirmal India 19 295 1.8× 102 0.7× 115 0.8× 47 0.3× 219 1.6× 73 1.1k
Kamel Besseghir Switzerland 21 398 2.5× 130 0.9× 145 1.0× 127 0.9× 222 1.6× 34 1.3k
Maha M. Amin Egypt 20 483 3.0× 56 0.4× 142 1.0× 79 0.6× 182 1.3× 47 1.1k
Felipe Varum United Kingdom 18 513 3.2× 156 1.1× 136 1.0× 55 0.4× 31 0.2× 23 1.1k
Kazunori Iwanaga Japan 23 459 2.8× 153 1.1× 323 2.3× 156 1.1× 41 0.3× 61 1.5k

Countries citing papers authored by Kunlun Wang

Since Specialization
Citations

This map shows the geographic impact of Kunlun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunlun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunlun Wang more than expected).

Fields of papers citing papers by Kunlun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunlun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunlun Wang. The network helps show where Kunlun Wang may publish in the future.

Co-authorship network of co-authors of Kunlun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kunlun Wang. A scholar is included among the top collaborators of Kunlun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunlun Wang. Kunlun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yang, Hui, Kunlun Wang, Yan Li, et al.. (2022). Local Ablative Treatment Improves Survival in ESCC Patients With Specific Metastases, 2010–2016: A Population-Based SEER Analysis. Frontiers in Oncology. 12. 783752–783752. 3 indexed citations
4.
Meng, Yuting, Kunlun Wang, Junfang Wang, et al.. (2022). EML4-ALK G1202R mutation induces EMT and confers resistance to ceritinib in NSCLC cells via activation of STAT3/Slug signaling. Cellular Signalling. 92. 110264–110264. 21 indexed citations
5.
Li, Yan, Kunlun Wang, Erjiang Zhao, et al.. (2022). Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma. Pathology & Oncology Research. 28. 1610245–1610245. 9 indexed citations
6.
9.
Yang, Hui, Kunlun Wang, Mengxi Li, et al.. (2020). The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer. Frontiers in Oncology. 10. 300–300. 31 indexed citations
10.
Qiu, Yanfang, Jie You, Kunlun Wang, et al.. (2019). Effect of whole-course nutrition management on patients with esophageal cancer undergoing concurrent chemoradiotherapy: A randomized control trial. Nutrition. 69. 110558–110558. 58 indexed citations
12.
Liu, Baoxing, Yacong Bo, Kunlun Wang, et al.. (2017). Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials. Oncotarget. 8(12). 20410–20417. 28 indexed citations
13.
Bo, Yacong, Kunlun Wang, Yang Liu, et al.. (2016). The Geriatric Nutritional Risk Index Predicts Survival in Elderly Esophageal Squamous Cell Carcinoma Patients with Radiotherapy. PLoS ONE. 11(5). e0155903–e0155903. 74 indexed citations
14.
Wang, Kunlun, Xiuhua Zhao, Yuangang Zu, et al.. (2015). Ultrafine Resveratrol Particles: Supercritical Antisolvent Preparation and Evaluation In Vitro and In Vivo. Advances in Materials Science and Engineering. 2015. 1–10. 6 indexed citations
15.
Li, Fang, Yueyun Wang, Yu Lan, et al.. (2015). Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection. Journal of Virology. 89(10). 5602–5614. 193 indexed citations
16.
Zu, Yuangang, Na Li, Xiuhua Zhao, et al.. (2014). In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H. International Journal of Pharmaceutics. 464(1-2). 1–9. 29 indexed citations
17.
Zhao, Xiuhua, Shan Chang, Yuangang Zu, et al.. (2013). Preparation, characterization, and evaluation in vivo of Ins-SiO2-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin. International Journal of Pharmaceutics. 454(1). 278–284. 48 indexed citations
18.
Zu, Yuangang, Wei Sun, Xiuhua Zhao, et al.. (2013). Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation. European Journal of Pharmaceutical Sciences. 53. 109–117. 79 indexed citations
19.
Deng, Shuixiang, et al.. (2013). Procalcitonin as a marker of sepsis and outcome in patients with neurotrauma: an observation study. BMC Anesthesiology. 13(1). 48–48. 13 indexed citations
20.
Zu, Yuangang, Ying Zhang, Xiuhua Zhao, et al.. (2011). Preparation and characterization of chitosan–polyvinyl alcohol blend hydrogels for the controlled release of nano-insulin. International Journal of Biological Macromolecules. 50(1). 82–87. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026